Over the past few days, as the rest of the stock market melted down, a revolution has been quietly brewing in the market for ...

FDA ends GLP-1 drug shortage. Concerns over safety, counterfeit drugs, and high cost of brand-name versions persist; ...

The company wants to create two focused companies dedicated to driving current and future value in their respective ...

As it gets harder to offer compounded GLP-1s, many telehealth companies are pivoting to hormone replacement therapy.

The GLP-1 weight loss market is a massive one ... While analysts were hoping to see weight loss of up to 25%, the company ...

Terns Pharmaceuticals is a small-cap biotech with a couple of weight loss candidates in its pipeline. The stock's price ...

CordenPharma, a CDMO focused on peptides and peptide-based therapeutics, announced a partnership with Viking Therapeutics. The two companies will work together to ensure the production of Viking’s GLP ...

Eli Lilly (LLY) believes its experimental weight-loss pill could make GLP-1 treatments more accessible worldwide.

Drugs like Ozempic have a positive impact on weight loss, though only for a short period, with long-term health implications ...